GLP2-T

CAS: 2023788-19-2

|

SKU:6384

GLP2-T is a synthetic peptide analogue engineered for laboratory research involving dual incretin-related receptor signaling, specifically glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor systems.

Current Lot ID
2602-C102-10-001, 2602-C102-20-001, 2602-C102-30-001, 2602-C102-60-001
Third-party analytical validation via HPLC & MS / Sequence matching verified

Research Use Only

This product is intended for research purposes only.

Configure Order

Select quantity and verify pricing.
SELECT CONCENTRATION
VOLUME PRICING
1
Technical Specification

Scientific Context & Applications

Research Profile Access

View extended technical data, molecular targets, signaling pathways, and historical research timelines for GLP2-T

Scientific Context
Molecular classification and background.

GLP2-T is classified as a dual incretin-receptor research peptide, designed to engage both GIP-associated and GLP-1-associated receptor pathways within experimental systems. Dual-receptor agonist constructs are used in research settings to explore:
  • Receptor co-activation dynamics
  • Signal amplification and attenuation mechanisms
  • Cross-talk between incretin-related signaling cascades
Studies involving GLP2-T focus on molecular and cellular signaling behavior, rather than physiological, therapeutic, or clinical outcomes. Observations are limited to controlled experimental conditions.

Laboratory Applications
Experimental models and settings.

GLP2-T is utilized in non-clinical research environments as a signaling probe to examine incretin-related receptor interactions and intracellular response patterns. Reported experimental contexts include:
  • Receptor Signaling Studies Used in cellular systems to evaluate GIP and GLP-1 receptor activation patterns, downstream second-messenger signaling, and pathway integration.
  • Pancreatic-Derived Cell Models Examined in beta-cell–derived or surrogate cell systems to study receptor-mediated signal transduction, without clinical interpretation.
  • Metabolic Signaling Research Applied in laboratory models to investigate lipid- and glucose-associated signaling pathways at the molecular level.
  • Cellular Stress & Signal Response Models Utilized in controlled experimental settings to assess cellular signaling responses to receptor engagement, independent of therapeutic context.
All applications are strictly investigational and confined to laboratory research use only. Research involving GLP2-T is exploratory and model-specific. Findings observed in cellular or animal research systems are not predictive of outcomes in humans or animals outside controlled laboratory conditions. No conclusions regarding safety, efficacy, metabolic outcomes, or clinical relevance have been established.

Scientific References
Peer-reviewed literature data.

Selected peer-reviewed literature examining dual incretin receptor signaling and unimolecular agonist design:
  1. Coskun T, et al. Dual GIP/GLP-1 receptor agonist signaling mechanisms. Molecular Metabolism
  2. Finan B, et al. Unimolecular dual incretin peptides in experimental systems. Science Translational Medicine
  3. Thomas MK, et al. Dual incretin receptor activation in controlled research models. Diabetes Care
(Clinical efficacy, safety, or therapeutic studies are intentionally excluded from commerce pages.)

Related Research Compounds

Explore compounds frequently investigated in similar research domains and signaling pathways.

Hospira Bac Water – 30ml

Kisspeptin

374675-21-5

GLP1-S

910463-68-2

5-Amino-1MQ

42464-96-0

Immune & Inflammatory Signaling Bundle

GH Axis & Endocrine Signaling Bundle

Neuro-Signaling & Neuropeptide Bundle

Mitochondrial & Cellular Energy Bundle

Structural & Cytoskeletal Research Bundle